BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21774990)

  • 1. Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression.
    Satomura E; Baba H; Nakano Y; Maeshima H; Suzuki T; Arai H
    J Affect Disord; 2011 Dec; 135(1-3):332-5. PubMed ID: 21774990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
    Shimizu E; Hashimoto K; Okamura N; Koike K; Komatsu N; Kumakiri C; Nakazato M; Watanabe H; Shinoda N; Okada S; Iyo M
    Biol Psychiatry; 2003 Jul; 54(1):70-5. PubMed ID: 12842310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.
    Emon MPZ; Das R; Nishuty NL; Shalahuddin Qusar MMA; Bhuiyan MA; Islam MR
    BMC Res Notes; 2020 Feb; 13(1):83. PubMed ID: 32085720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Brain-derived neurotrophic factor (BDNF): the severity and symptomatic dimensions of depression.
    Jevtović S; Karlović D; Mihaljević-Peleš A; Šerić V; Vrkić N; Jakšić N
    Psychiatr Danub; 2011 Dec; 23(4):363-9. PubMed ID: 22075737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower levels of brain-derived neurotrophic factor are associated with melancholic psychomotor retardation among depressed inpatients.
    Primo de Carvalho Alves L; Sica da Rocha N
    Bipolar Disord; 2018 Dec; 20(8):746-752. PubMed ID: 29516593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression.
    Nomoto H; Baba H; Satomura E; Maeshima H; Takebayashi N; Namekawa Y; Suzuki T; Arai H
    BMC Psychiatry; 2015 Mar; 15():33. PubMed ID: 25885038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood BDNF level is gender specific in severe depression.
    Kreinin A; Lisson S; Nesher E; Schneider J; Bergman J; Farhat K; Farah J; Lejbkowicz F; Yadid G; Raskin L; Koman I; Pinhasov A
    PLoS One; 2015; 10(5):e0127643. PubMed ID: 26010085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the association between depression, suicidality and serum neurotrophin levels in adolescents.
    Bilgiç A; Çelikkol Sadıç Ç; Kılınç İ; Akça ÖF
    Int J Psychiatry Clin Pract; 2020 Jun; 24(2):143-150. PubMed ID: 32027188
    [No Abstract]   [Full Text] [Related]  

  • 12. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic factors, clinical features and gender differences in depression.
    de Azevedo Cardoso T; Mondin TC; Wiener CD; Marques MB; Fucolo Bde Á; Pinheiro RT; de Souza LD; da Silva RA; Jansen K; Oses JP
    Neurochem Res; 2014 Aug; 39(8):1571-8. PubMed ID: 24899094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.
    Martocchia A; Curto M; Scaccianoce S; Comite F; Xenos D; Nasca C; Falaschi GM; Ferracuti S; Girardi P; Nicoletti F; Falaschi P
    Aging Clin Exp Res; 2014 Aug; 26(4):461-4. PubMed ID: 24435333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression.
    Fang Y; Qiu Q; Zhang S; Sun L; Li G; Xiao S; Li X
    J Affect Disord; 2018 Feb; 227():745-751. PubMed ID: 29689690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
    Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
    J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.
    Gupta K; Gupta R; Bhatia MS; Tripathi AK; Gupta LK
    J Clin Pharmacol; 2017 Dec; 57(12):1519-1526. PubMed ID: 28833192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
    Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
    J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.